iNtRON Biotechnology, Inc. (KOSDAQ:048530)
South Korea · Delayed Price · Currency is KRW 2,845.00
-45.00 (-1.56%)
Sep 22, 2026, 3:30 PM KST
iNtRON Biotechnology Market Cap
iNtRON Biotechnology has a market cap or net worth of 87.89 billion as of September 22, 2026. Its market cap has decreased by -30.67% in one year.
Market Cap
87.89B
Enterprise Value
49.47B
Revenue
5.74B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,845.00
ChartMarket Cap Chart
Since January 26, 2011, iNtRON Biotechnology's market cap has decreased from 95.30B to 87.89B, a decrease of -7.78%. That is a compound annual growth rate of -0.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 87.89B | -14.46% |
| Dec 30, 2025 | 102.75B | -44.03% |
| Dec 30, 2024 | 183.56B | -37.01% |
| Dec 28, 2023 | 291.42B | 7.98% |
| Dec 29, 2022 | 269.88B | -61.99% |
| Dec 30, 2021 | 710.00B | -22.41% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anterogen.Co.,Ltd. | 145.79B |
| Helixmith | 138.14B |
| Genexine | 135.98B |
| Vaxcell-Bio Therapeutics | 101.52B |
| MedPacto | 93.57B |
| Prestige BioPharma | 69.95B |
| ENCell | 65.85B |
| Amicogen | 62.56B |